Form 4 holding
General Counsel
Verona Pharma plc
- Security class
- Ordinary Shares
- Shares / value
- 1,623,487
- Estimated value
- $32,469,740
- Report date
- 01 Feb 2024
- Price
- $20.00
- Ownership
- Direct
Claire Poll
Insider Reports History
- Reporting-owner location
- London, United Kingdom
- Latest reporting-owner signature
-
/s/ Claire Poll
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Claire Poll
Form 4 holding
General Counsel
Verona Pharma plc
- Security class
- Ordinary Shares
- Shares / value
- 1,176,920
- Estimated value
- $23,538,400
- Report date
- 01 Feb 2024
- Price
- $20.00
- Ownership
- By Trust
Insider Reports Filed by Claire Poll
4
VRNA
Verona Pharma plc
- Report period
- 01 Feb 2024
- Transactions
- 3
- Transaction value
- -$237,197
- Accepted by SEC
- 05 Feb 2024, 18:10
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Nov 2023
- Transactions
- 3
- Transaction value
- -$303,254
- Accepted by SEC
- 03 Nov 2023, 20:09
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 20 Oct 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 24 Oct 2023, 16:06
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 03 Aug 2023
- Transactions
- 5
- Transaction value
- -$121,914
- Accepted by SEC
- 07 Aug 2023, 21:15
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Aug 2023
- Transactions
- 2
- Transaction value
- -$83,415
- Accepted by SEC
- 03 Aug 2023, 20:30
- Role
- General Counsel
- Next action
- Open filing details
4/A
VRNA
Verona Pharma plc
- Report period
- 01 May 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 11 May 2023, 16:16
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 20 Jan 2023
- Transactions
- 7
- Transaction value
- -$394,273
- Accepted by SEC
- 03 Feb 2023, 17:15
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 26 Sep 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Sep 2022, 16:06
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Aug 2022
- Transactions
- 1
- Transaction value
- -$53,730
- Accepted by SEC
- 03 Aug 2022, 16:10
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 May 2022
- Transactions
- 1
- Transaction value
- -$41,746
- Accepted by SEC
- 03 May 2022, 20:19
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Feb 2022
- Transactions
- 1
- Transaction value
- -$62,023
- Accepted by SEC
- 03 Feb 2022, 16:55
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 21 Nov 2021
- Transactions
- 11
- Transaction value
- -$646,032
- Accepted by SEC
- 27 Dec 2022, 17:50
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Nov 2021
- Transactions
- 1
- Transaction value
- -$51,133
- Accepted by SEC
- 03 Nov 2021, 19:51
- Role
- General Counsel
- Next action
- Open filing details
4
VRNA
Verona Pharma plc
- Report period
- 01 Aug 2021
- Transactions
- 3
- Transaction value
- -$250,886
- Accepted by SEC
- 03 Aug 2021, 21:59
- Role
- General Counsel
- Next action
- Open filing details